The Research Enterprise of the 198Os

The New Alliance: America's R&D Consortia. Dan Dimancescu and James Botkin. Ballinger Publishing Co., Cambridge, MA, 1986. 232 pp. $29.95. In just over 200 pages, the authors of The New Alliance skillfully analyze the mechanics of a question of strategic importance to the future of the United States: can the technology-based consortia of the 1980s make the nation's economy competitive again? The strong and weak forces, as well as the changing nature of 14 representative industry-university-gov

Written byJohn Hague
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The strong and weak forces, as well as the changing nature of 14 representative industry-university-government consortia in 10 states, are intricately examined. The profiles that emerge are based on discussions with consortia participants during 1984 and 1985, and factual updates in 1986.

The organizations under study include the Manufacturing Engineering Applications Center, Worcester, Mass.; the Center for Integrated Systems, Palo Alto, Calif.; the Microelectronics and Computer Technology Corporation, Austin, Texas; the Corporation for Science and Technology, Indianapolis, Ind., the Center for Industrial Innovation, Troy, N.Y.; and the Microelectronics Center of North Carolina, Research Triange Park, N.C. These and others are examples of the research and development consortia of the 1980s that, according to the authors, "came forward as a great experiment in truly American style without master blueprints or even a clear sense of the ultimate outcome."

The book describes the consortin, which are depicted as precursors of fundamental change, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies